Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia: No Impact of Pre-transplant Extramedullary Disease on Outcome

The impact of extramedullary disease (EMD) in AML on the outcomes of allogeneic hematopoietic cell transplantation (alloHCT) is unknown. Using data from the Center for International Blood and Marrow Transplant Research (CIBMTR) we compared the outcomes of patients who had EMD of AML at any time prio...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Bone Marrow Transplant
Glavni autori: Goyal, Sagun D., Zhang, Mei-Jie, Wang, Hai-Lin, Akpek, Görgün, Copelan, Edward A., Freytes, César, Gale, Robert Peter, Hamadani, Mehdi, Inamoto, Yoshihiro, Kamble, Rammurti T., Lazarus, Hillard M., Marks, David I., Nishihori, Taiga, Olsson, Richard F., Reshef, Ran, Ritchie, David S., Saber, Wael, Savani, Bipin N., Seber, Adriana, Shea, Thomas C., Tallman, Martin S., Wirk, Baldeep, Bunjes, Donald W., Devine, Steven M., de Lima, Marcos, Weisdorf, Daniel J., Uy, Geoffrey L.
Format: Artigo
Jezik:Inglês
Izdano: 2015
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4527880/
https://ncbi.nlm.nih.gov/pubmed/25915806
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bmt.2015.82
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items